Epithelial tight junction (ZO-1 / Occludin) reinforcement and barrier repair
Epithelial Tight Junction Assembly · Biological barrier integrity and extracellular matrix
Either supplies energy directly or stimulates assembly of the tight junction complex through protein kinase signaling. This anchors the actin cytoskeleton, seals the paracellular pathway and lowers epithelial permeability.
Supplements acting on this mechanism (ranked by strength and evidence)
L-glutamine
Glutamine is a key metabolic fuel for intestinal epithelial cells. In animal experiments, it can increase occludin expression and lower permeability. In a randomized human trial in post-infectious diarrhea-predominant IBS, the permeability ratio fell, but this does not directly prove tight junction protein assembly.
Zinc carnosine (PepZin GI)
A small randomized human trial showed that zinc carnosine can reduce the rise in intestinal permeability caused by indomethacin. Whether it works through EGF, Hsp70 or occludin has not been directly confirmed in humans; the molecular evidence comes mainly from experimental studies.
Berberine
In mouse intestinal injury models and some cell models, berberine can improve the epithelial barrier, but a better barrier does not always come with higher total levels of tight junction proteins. Effects in humans and dependence on MLCK have yet to be verified, and there is no direct confirmation from intestinal biopsies.
Sodium butyrate / tributyrin
Butyrate is an important fuel for colonic epithelial cells. In animal models, including mice with scald burns, it can reduce the rise in intestinal permeability and the tight junction protein abnormalities. How much of a standard oral product reaches the human colon, and how ZO-1 and Occludin respond in humans, has not been established.
Tauroursodeoxycholic acid (TUDCA)
Evidence for improved intestinal tight junctions comes mainly from mice on a high-fat diet and from colitis models. TUDCA can restore some tight junction-related gene expression and reduce the downregulation of ZO-1 and occludin. No reliable human study has directly measured tight junction proteins at routine oral doses.
Resistant starch (RS2/RS3)
Evidence for improved tight junctions comes mainly from diabetic mouse studies. Butyrate can fuel the colonic epithelium, but a randomized crossover trial in people with metabolic syndrome did not show a clear improvement in permeability, and junction protein changes in humans have not been confirmed.
Akkermansia muciniphila (pasteurized postbiotic)
In animal studies, inactivated bacteria can upregulate tight-junction proteins such as ZO-1 and occludin and limit their downregulation. In humans, changes in blood endotoxin or metabolic markers cannot prove that tight-junction proteins are upregulated, nor do they show that bacterial products entering the blood are fully blocked.
Deglycyrrhizinated licorice (DGL)
One animal study of the intestinal barrier showed that a specific deglycyrrhizinated licorice flavonoid extract can improve intestinal permeability and regulate tight junction proteins. This evidence comes from a specific extract and an intestinal model, so it cannot be applied directly to all DGL chewable tablets or to the human stomach and esophagus.
Saccharomyces boulardii
The protease secreted by the yeast can break down toxins from pathogenic E. coli and Clostridioides difficile in vitro. In a mouse colitis model, barrier markers such as ZO-1 and occludin improved, but human studies did not measure tight junction proteins directly. Toxin breakdown and tight junction repair are two different actions.
Rutin / troxerutin
A mouse dietary study showed that rutin improved intestinal ZO-1, occludin and claudin-1 expression after cold stress. The adherens junctions of capillary endothelium are different from the epithelial tight junctions discussed here. The effect of oral rutin on tight junction proteins in humans is still uncertain.
Low molecular weight hyaluronic acid
In mice given it orally, 35 kDa hyaluronic acid increased ZO-1 expression in the colonic epithelium and improved barrier function in an infection model. That molecular weight differs from the 50–200 kDa of this product, and extracellular water retention is not the same as stronger tight junctions. The related mechanism has not been confirmed in human keratinocytes.
Triphala standardized extract (chebulic myrobalan, amla, belleric myrobalan)
In an oral dosing study in rats, Triphala raised intestinal ZO-1 and claudin-1 expression and improved permeability-related markers. A protective film formed by tannins and mucosal proteins is not the same as repair of tight junctions, and improvement in human “leaky gut” has not been confirmed.
Bovine colostrum immunoglobulin (IgG 40%+)
Growth factors in bovine colostrum are thought to promote proliferation of intestinal crypt epithelial cells and to affect the assembly of tight junction proteins. However, it has not been directly shown that ZO-1 and Occludin increase as a result in humans, and intestinal permeability results from small trials are inconsistent.
Silybin phytosome
In mouse intestinal barrier studies, silybin-associated changes in the gut microbiota were accompanied by upregulation of tight junction proteins. This is not the same as improved liver microcirculation or a better bile duct epithelial barrier. Tight junction repair in humans after taking the phospholipid complex orally has not been directly shown.
Lactoferrin
In animal and cell models, lactoferrin can improve a damaged intestinal barrier and increase expression of tight junction proteins such as ZO-1 and occludin. Neither a pro-proliferative effect on small-intestine crypt stem cells nor tight junction repair after oral intake in humans has been established so far.
Astragaloside IV
In an animal colitis model, colonic tight junction markers such as ZO-1 and Occludin improved after oral astragaloside IV. The doses in this model were relatively high, so it cannot be assumed that the dose used here is effective in humans.
Galactooligosaccharides (GOS)
In animal models of intestinal injury, galactooligosaccharides can upregulate tight junction-related genes such as ZO-1 and occludin. Direct human evidence is insufficient, and changes in inflammatory or stress markers do not prove that tight junctions were repaired.
Dihydroberberine (DHB)
In mouse colitis models, dihydroberberine can raise tight junction proteins and mucin-related markers. Local exposure in the gut makes this result biologically plausible. However, there is no direct human evidence for the same mechanism, and neither ileal ZO-1 upregulation nor a microbiota-mediated pathway has been confirmed.
Soy or egg yolk lecithin (high-purity polyenylphosphatidylcholine, PC)
Phospholipids are an important part of cell membranes, and in animal experiments oral PC can reduce the inflammation-induced rise in gastrointestinal permeability. This mostly reflects protection of the mucus surface barrier. It has not been shown that ordinary PC directly reinforces tight junction structures such as ZO-1 or Occludin.